Dyspnoea is a presenting symptom for patients with heart failure. It is often due to elevated left ventricular (LV) filling pressure but can be due to pulmonary disease or other non-cardiac reasons. While physical examination is useful, it has its limitations. Accordingly, non-invasive imaging has an important role in the diagnostic evaluation of patients with known or suspected heart failure. Echocardiography is usually the first test obtained and is used to determine LV volumes, ejection fraction and mass as well as right ventricular size and function, left and right atrial volumes, valvular lesions, and pulmonary artery pressures. Additionally, LV filling pressure can be estimated. A recent algorithm was published that depends on clinical, two-dimensional data and Doppler signals. The algorithm is accurate in patients with depressed and normal ejection fraction. There are other measurements that can be obtained as LV strain and diastolic strain rate and left atrial strain. These indices provide valuable insight into LV relaxation and filling pressure as well as left atrial function. Assessment of LV filling pressure has been evaluated most extensively in patients in sinus rhythm. However, it is also possible to assess LV filling and draw inferences about LV filling pressure in patients in atrial fibrillation, in patients with mitral valve disease and in patients with left ventricular assist devices. Left ventricular filling has been assessed by other imaging modalities, including cardiac computed tomography and cardiac magnetic resonance. While these other imaging modalities may be needed in some cases, echocardiography has the highest feasibility and validation, and the most practical application. Many patients present with dyspnoea which could be the first manifestation of congestive heart failure. Clinical assessment, along with chest X-ray and serum biomarkers, is the first step in the evaluation of these patients. However, there are limitations to clinical evaluation and thus the need for non-invasive imaging for assessment of left ventricular (LV) filling pressure. For example, it can be difficult to determine jugular venous pressure in obese patients and physical examination skills are different between experienced clinicians and physicians in training. Echocardiography, radionuclide angiography, cardiac computed tomography and cardiac magnetic resonance have all been used to obtain the rates of LV diastolic filling in early and late diastole. In the presence of impaired LV relaxation but normal left atrial (LA) pressure, LV filling rate in early diastole is reduced with predominant filling in late diastole.
Many patients present with dyspnoea which could be the first manifestation of congestive heart failure. Clinical assessment, along with chest X-ray and serum biomarkers, is the first step in the evaluation of these patients. However, there are limitations to clinical evaluation and thus the need for non-invasive imaging for assessment of left ventricular (LV) filling pressure. For example, it can be difficult to determine jugular venous pressure in obese patients and physical examination skills are different between experienced clinicians and physicians in training. Echocardiography, radionuclide angiography, cardiac computed tomography and cardiac magnetic resonance have all been used to obtain the rates of LV diastolic filling in early and late diastole. In the presence of impaired LV relaxation but normal left atrial (LA) pressure, LV filling rate in early diastole is reduced with predominant filling in late diastole.
1 However, as LA pressure increases, LV filling in early diastole increases again. Accordingly, LV filling rates and mitral inflow velocities cannot be used in isolation to estimate LV filling pressure without knowledge of the status of LV relaxation. Over the past 15-20 years, other indices of LV relaxation were introduced, including early diastolic flow propagation velocity (obtained by colour M-mode), mitral annulus early diastolic velocity (e ′ ), and diastolic strain rates, all measured by echocardiography, 1 though e ′ velocity has also been measured by cardiac magnetic resonance, 2 and cardiac computed tomography. 3 While the above signals have been validated against the invasive gold standard of the time constant of LV relaxation, each of the variables has its limitations. These include technical limitations that affect the quality of the acquired signal as well as pathologic limitations where a particular signal is affected by other variables than LV relaxation. For example, mitral annulus e ′ velocity in patients with severe mitral regurgitation (MR) and normal LV ejection fraction (LVEF) is related not only to LV relaxation but importantly to LV stroke volume. 4 Table 1 presents a summary of the individual signals that can be used for the assessment of LV diastolic function and their limitations. Accordingly, recent ASE/EACVI guidelines have emphasized an algorithm approach that is based on the combination of several 
Mitral E/A ratio
Mitral inflow E/A ratio and DT relate to LA pressure and LV diastolic function. An increased E/A ratio in patients with myocardial disease is associated with increased LA pressure and a short DT is associated with increased LV chamber stiffness and increased LV filling pressure. Arrhythmias, significant mitral stenosis and/or regurgitation are among the limitations. Changes in mitral inflow with Valsalva manoeuvre When E/A ratio decreases with Valsalva ≥50%, LA pressure is usually increased. The difficulty in standardizing the effort and the use of mechanical intubation are limitations to its application. Mitral "L" velocity An "L" wave occurs in mid-diastole and is seen in patients with diastolic dysfunction and elevated LA pressure. When ≥50 cm/s, it is a specific finding of diastolic dysfunction and elevated LA pressure. However, it is usually seen in the presence of bradycardia, which decreases its detection in the presence of normal or fast heart rates. Mitral annulus early diastolic velocity (e ′ )
T h e e ′ velocity is related to LV relaxation and suction as well as the transmitral pressure gradient. In normal hearts, LA pressure has a strong effect on e ′ velocity. However, its delay when there is myocardial dysfunction shields from the peak transmitral pressure gradient and makes it possible to utilize it as an index of LV relaxation. The presence of mitral stenosis, significant mitral regurgitation, surgical ring, prosthetic mitral valve, moderate to severe mitral annulus calcification, left bundle branch block and ventricular pacing are among its limitations. Mitral E/e ′ ratio A dimensionless parameter that is directly related to LA pressure. Limitations to its use include mitral stenosis, significant mitral regurgitation, surgical ring, prosthetic mitral valve, moderate to severe mitral annulus calcification, left bundle branch block, ventricular pacing, pericardial disease and in normal hearts.
LA maximum volume index
In patients with diastolic dysfunction, LA maximum volume reflects the effects of a chronic increase in LA pressure. However, it does not change rapidly in response to changes in LA pressure. Further, it is often increased in other conditions as in athletes, patients in atrial fibrillation, patients with mitral valve disease, heart transplants and high cardiac output states.
Pulmonary veins: systolic (S) velocity, diastolic (D) velocity, and S/D ratio
The S velocity and the S/D ratio decrease when LA pressure is elevated. However, these findings are less reliable in patients with normal LVEF. The presence of mitral stenosis or significant mitral regurgitation are among the limitations to the use of these velocities and their ratio. In addition, in intubated patients, there is a low feasibility in recording pulmonary venous flow in intensive care unit patients.
Ar-A duration
The time difference between the duration of atrial velocity in pulmonary venous flow and the duration of mitral A velocity is related to LVEDP. It can be challenging to acquire pulmonary venous flow in intensive care unit patients and the Ar-A duration is not applicable in patients with atrial arrhythmias including atrial fibrillation, sinus tachycardia as well as in patients in heart block. CW Doppler TR systolic jet velocity Patients with increased LA pressure usually have increased peak TR velocity due to elevated PA systolic pressure. However, intravenous saline or echocardiography contrast agents may be needed to enhance the signal and thus obtain reliable measurements of the peak velocity. Further, the velocity is less useful in patients with primary pulmonary disease and the clinical context should be carefully examined before relying on peak TR velocity to draw inferences about LA pressure.
A, atrial filling; Ar, atrial reversal velocity in pulmonary veins; CW, continuous wave; DT, deceleration time of mitral E velocity; E, early filling; LA, left atrial; LV, left ventricular; LVEDP, left ventricular end-diastolic pressure; LVEF, left ventricular ejection fraction; PA, pulmonary artery; TR, tricuspid regurgitation.
parameters with high feasibility and reproducibility. 1 The approach is dependent on the correct identification of patients with myocardial disease.
How to identify the presence of cardiac disease
The algorithm recommended in the 2016 guidelines is based on the assumption that myocardial disease is present, 1 
Left ventricular diastolic pressures
The lowest LV pressure in early diastole is the minimal pressure and it is most reliably measured using high fidelity pressure catheters. After mitral valve opening, LV filling begins and LV pressure initially falls (during active LV relaxation), and thereafter increases following the LV pressure-volume curve as determined by LV stiffness. The LV diastolic pressure prior to LA contraction is the LV pre-A pressure ( Figure 1) . It is very similar to mean LA pressure and mean wedge pressure. 5 After LA contraction, LV pressure rises (A wave rise in LV pressure recording) and eventually, LVEDP is reached. Both LV pre-A pressure and LVEDP can be reliably measured using fluid filled catheters. The 2016 algorithm is based on the prediction of mean wedge pressure and not LVEDP, 1 since it is the wedge pressure that is associated with the alveolar capillary transmural pressure and, in turn, pulmonary congestion. Notwithstanding, there are specific signals that can be used to draw inferences about LVEDP.
Doppler indices of elevated left ventricular end-diastolic pressure
Patients with diastolic dysfunction can have normal LV diastolic pressures at rest. At a later stage, LVEDP increases but mean LA pressure can still be normal. To identify patients at this stage, Doppler signals that occur at end diastole are analysed. The rationale for using these signals will be discussed briefly.
Flow across the mitral valve is related to the transmitral pressure gradient. The LVEDP is abnormally elevated in patients with increased LV stiffness. The increase in LVEDP, which is the afterload against which the left atrium contracts, leads to a decrease in both . LA contractility and the late diastolic transmitral pressure gradient with abbreviated flow across the mitral valve in late diastole. Thus, mitral peak A velocity and duration decrease as well as the fraction of LV filling due to LA contraction (atrial filling fraction). Further, mitral A velocity deceleration time (how fast the velocity decreases with time) becomes shorter. In addition, pulmonary vein flow into the left atrium can help confirm the presence of elevated LVEDP with good accuracy. 6, 7 When the left atrium contracts in late diastole, forward flow across the mitral valve into the left ventricle and backward flow into the pulmonary vein take place at the same time. When LVEDP is increased, the duration of retrograde flow into the pulmonary vein exceeds the duration of antegrade flow into the left ventricle, and a time difference in the duration of pulmonary vein atrial reversal velocity and mitral A velocity ≥30 ms is a good indicator of elevated LVEDP ( Figure 2 ). This parameter does not change with age and thus can be used to draw inferences about LVEDP irrespective of the age of a given patient. 8 The main limitations to its application include lower feasibility in patients in intensive care units, the presence of LA systolic dysfunction, and in atrial fibrillation/flutter/tachycardia or atrioventricular block. Mitral annulus late diastolic velocity (a') is reduced in patients with elevated LVEDP ( Figure 3 ) and has been shown to predict outcome in patients with heart failure due to reduced LVEF. 9 When present, a B-bump in the M-mode recording of mitral leaflets is another useful finding to confirm the presence of elevated LVEDP, though it appears to have a lower prevalence than the other signals discussed above. of the mitral annulus from a male patient with heart failure and reduced ejection fraction. This patient has elevated left ventricular end-diastolic pressure as late diastolic mitral annulus velocity (a ′ ) is reduced. He has impaired left ventricular relaxation as can be inferred from the reduced early diastolic velocity (e ′ ). The arrow points to brief diastolic recoil of the mitral annulus during the isovolumic relaxation period. patient population, largely based on analysis of mitral inflow and pulmonary venous flow velocities (Figure 4 ). In the presence of sinus rhythm, patients with elevated LA pressure exhibit an increased mitral E/A ratio, and a decreased pulmonary vein systolic to diastolic (S/D) velocity ratio. Pulmonary vein flow into the left atrium occurs during systole and diastole due to a positive pressure gradient between the pulmonary veins and the left atrium. An increased LA pressure decreases the gradient and thus pulmonary vein flow into the left atrium. Since the left atrium empties into the left ventricle during diastole with the y-descent in LA pressure, the pulmonary vein-LA pressure gradient is higher during diastole than during systole, leading to a higher pulmonary vein diastolic velocity and thus a lower S/D velocity ratio.
10 Importantly, an E/A ratio ≥2 (restrictive filling pattern) has a high accuracy in identifying heart failure with reduced ejection fraction (HFrEF) patients with elevated LV filling pressure.
11,12
In comparison, in patients with LV diastolic dysfunction, when LA pressure is normal, mitral E/A ratio is <1 (impaired relaxation pattern) and pulmonary vein S/D ratio is >1. In particular, an E/A ratio ≤0.8 and mitral E velocity ≤50 cm/s are reliable signals in identifying the presence of normal LV filling pressure.
1
In addition to the diagnostic utility of the Doppler signals, there are numerous large multicentre observational studies that have confirmed the incremental prognostic value of Doppler measurements in patients with HFrEF, and in patients presenting with acute myocardial infarction and depressed LVEF.
13 -17 Tracking the changes in the LV filling pattern can allow for more refined prediction models as patients with a persistently restrictive filling pattern despite medical treatment have worse outcomes.
18 -20 The most recent guidelines 1 emphasize the need to evaluate additional signals when the mitral inflow pattern is between these extremes ( Figure 5) . The recommended signals include LA maximum volume index, average mitral E/e ′ ratio, and peak tricuspid regurgitation (TR) velocity by continuous wave Doppler, as well as Figure 4 Mitral inflow (left) and pulmonary venous flow (right) from a patient with heart failure and reduced ejection fraction. Mitral early diastolic velocity (E) is much higher than late diastolic velocity (A) with E/A ratio >2 consistent with restrictive left ventricular filling. Pulmonary venous flow shows predominant flow into the atrium during diastole (D) with a reduced systolic to diastolic velocity ratio, which is consistent with elevated left atrial pressure. Ar, pulmonary vein atrial reversal; S, systole. pulmonary vein flow S/D ratio if one of the previous three signals is not available or is of suboptimal quality. The algorithm was recently tested in a large multicenter study and was shown to be not only highly reliable but also more accurate than clinical evaluation. 21 Another study in 159 patients reported fair accuracy of the algorithm in identifying patients with elevated LVEDP. 22 In that regard, it is important to note that the algorithm was constructed based on the estimation of mean wedge pressure and not LVEDP. Aside from the approach mentioned above, a CART analysis approach resulted in high accuracy in estimating wedge pressure in patients with LV dysfunction. 23 In the latter study, an average E/e ′ ratio ≥13 or an E velocity deceleration time <150 ms were closely associated with elevated LV filling pressure. 23 Importantly, most patients with elevated wedge pressure were correctly identified with a sensitivity of 87% and a specificity of 90%.
Estimation of left atrial pressure in patients with normal left ventricular ejection fraction
Estimation of LA pressure in patients with normal LVEF can be challenging if one is not able to identify the presence or absence of myocardial disease. Thus the importance of obtaining reliable clinical data and careful quantification of cardiac chamber dimensions and volumes before embarking on the exercise of estimating LV filling pressure. As noted above, clinical findings when combined with data on LV volumes and mass, LA volume, and indices of LV systolic performance can be used to draw inferences about the presence or absence of myocardial disease. A recent study looking at the incidence of heart failure in an elderly population confirmed the strong association of the cut-off values mentioned above with clinical status and the worse outcomes in patients with >1 abnormal parameter. 24 In the presence of myocardial disease, the 2016 guidelines approach can be applied ( Figure 5 ). Similar to patients with depressed LVEF, the first step is to examine the mitral inflow pattern and identify the two groups where additional data beyond mitral inflow are not needed-namely patients with an E/A ratio ≤0.8 and mitral E velocity ≤50 cm/s and patients with an E/A ratio ≥2. For values that do not fall within one of these two groups, average E/e ′ ratio, LA maximum volume index and peak TR velocity are considered. The algorithm had a good accuracy (84%) in identifying patients with heart failure and preserved ejection fraction (HFpEF), when applied to a large group of patients with normal LVEF who presented with shortness of breath. In the latter study, clinical evaluation including chest X-ray and NT-proBNP, had an accuracy of 64% only when invasive LV filling pressure was used as the gold standard. 21 There are other useful insights provided by echocardiography into cardiac function in patients with HFpEF. These include the development of secondary pulmonary arterial hypertension and RV systolic dysfunction. Right ventricular dysfunction can be detected by RV fractional area change <35%, tricuspid annular plane systolic excursion (TAPSE) <17 mm, and tricuspid annulus systolic velocity <9.5 cm/s. Importantly, increased pulmonary artery pressures and reduced RV function are predictors of worse outcomes in patients with HFpEF.
1
HFpEF patients have increased arterial elastance (ratio of end-systolic pressure to LV stroke volume; end-systolic pressure can be derived as: 0.9 x systolic blood pressure) and increased ratio of arterial elastance to LV end-systolic elastance. It is possible to use echocardiography in conjunction with arterial blood pressure to obtain both measurements, though they are not routine measurements and some studies have shown similar findings between HFpEF patients and patients with isolated diastolic dysfunction who are not in heart failure.
Estimation of left ventricular filling pressure in patients with atrial fibrillation
In patients with depressed LVEF, deceleration time of mitral inflow velocity gives a good assessment of mean wedge pressure. 25 A deceleration time ≤160 ms is consistent with elevated wedge pressure. In patients with normal LVEF, several indices can be obtained and used to draw inferences about LV filling pressure. 26 These include isovolumic relaxation time (IVRT, ≤65 ms), peak acceleration rate of mitral diastolic velocity (≥1900 cm/s 2 ), deceleration . Figure 6 shows Doppler signals from a patient in atrial fibrillation and elevated LV filling pressure. The LA maximum volume index is not useful as atrial fibrillation leads to LA enlargement in the absence of LV diastolic dysfunction.
Estimation of left ventricular filling pressure in patients with mitral valve disease and mitral annular calcification
In patients with isolated mitral stenosis, LVEDP is usually normal but LA pressure is elevated. IVRT which corresponds to the time interval between the aortic component of the second heart sound and the opening snap of the mitral valve when <60 ms has
IVRT

Figure 6
Mitral inflow from a patient in atrial fibrillation with increased left ventricular filling pressure. Peak diastolic velocity is close to 1.5 m/s with rapid acceleration from onset to peak velocity. There is little beat-to-beat variation despite varying RR interval. Isovolumic relaxation time (IVRT) is shown to the right (arrows) and is short. All of the above findings are consistent with elevated left ventricular filling pressure.
high specificity for elevated LA pressure. Further, an increased transmitral pressure gradient at end diastole and detected by a mitral A velocity >1.5 m/s supports the conclusion of elevated LA pressure.
1,4
In patients with haemodynamically significant MR, peak TR velocity (>2.8 m/s) and IVRT (<60 ms) are indicative of elevated LA pressure.
1,4 Pulmonary vein atrial reversal velocity duration that exceeds mitral inflow A velocity duration by ≥30 ms is consistent with LV diastolic dysfunction and elevated LVEDP in patients with haemodynamically significant MR. 27 Time intervals that compare the timing of onset of mitral E velocity to that of mitral annulus e ′ velocity can be applied in patients with mitral stenosis and/or MR, 4 though they require a longer time for analysis and the recording of more cardiac cycles to allow for matching RR intervals unless a dual Doppler probe is used, which allows recording mitral E and annular e ′ velocities from the same cardiac cycle. 28 In patients with moderate to severe mitral annular calcification, mitral inflow E/A ratio and IVRT can be used to estimate LV filling pressure. However, the E/e ′ ratio should not be used in this patient population.
1,29
Estimation of left ventricular filling pressure in patients with left ventricular assist devices
Left ventricular assist devices (LVADs) usually result in symptomatic improvement in patients with advanced heart failure. However, some patients may be left with significant symptoms or may have recurrence of dyspnoea after initial improvement. There are several reasons that can lead to shortness of breath in this patient population, which include cardiac and extra-cardiac factors as anaemia and metabolic acadaemia. They can also have an elevated LV filling pressure which could improve with increasing LVAD support. in a diagnostic algorithm, and evaluated in a test and in a validation population. The variables include mitral E/A ratio, LA maximum volume index, E/e ′ ratio, pulmonary artery systolic pressure and right atrial (RA) pressure as estimated by echocardiography ( Figure  7) . The algorithm had a good accuracy in identifying LVAD patients with elevated mean wedge pressure. Further, Doppler-based methodology for estimation of pulmonary artery pressures, RA pressure and cardiac index had satisfactory correlations with invasively measured pressures and cardiac index.
30
Other indices of left ventricular relaxation and left ventricular filling pressure
The rate and extent of LV expansion during diastole are indices of LV relaxation. The left ventricle expands faster in ventricles with normal relaxation, and LV global diastolic strain rate during the isovolumic relaxation period and during early diastole are reduced in the presence of impaired relaxation. There are invasive studies in animals and in humans showing the significant association of both measurements with the time constant of LV relaxation and -dP/dt. 31, 32 Further, the ratio of mitral peak E velocity to LV diastolic strain rate during the isovolumic relaxation period and during early diastole have been shown to predict mean wedge pressure, 32, 33 as well as clinical events in several patient populations including patients diagnosed with heart failure. 34 -36 Left atrial strain measurements have also been evaluated in patients with heart failure, and LA strain during systole has a significant inverse correlation with mean wedge pressure as well as LVEDP. 37 Further non-invasive indices of LA stiffness readily identified HFpEF patients from patients with isolated diastolic dysfunction. 38 While promising, the effects of mitral valve disease and atrial arrhythmias on LA strain have not been evaluated yet and may represent limitations to its clinical application.
Figure 7
Algorithm for estimation of left ventricular filling pressure in patients with left ventricular assist devices (LVAD). It is based on mitral inflow velocities, maximum left atrial volume index (LAVi), ratio of mitral peak early diastolic velocity to annular early diastolic velocity (E/e ′ ratio), right atrial pressure (RAP) and pulmonary artery systolic pressure (sPAP). PCWP, pulmonary capillary wedge pressure. Reproduced with permission from Estep et al. 30 The main limitation to the daily adoption of the above indices is the lower feasibility and reproducibility, which depends strongly on the quality of the images and the experience of the analysis team. It remains to be seen whether these indices offer special advantage in specific patient groups.
Evaluation of patients with dyspnoea, normal left ventricular ejection fraction, and normal left atrial pressure at rest
This is an important category of patients where the question of HFpEF remains given the presence of normal LA pressure at rest. In these patients, exercise, which is usually accompanied by increased blood pressure and heart rate, often leads to an elevated LV filling pressure. This is due to the effects of increased blood pressure on slowing and delaying LV relaxation and, thus, LV early diastolic pressures and, in turn, LA pressure increase to maintain LV filling and stroke volume. The increased heart rate abbreviates the available duration for the decline in LV pressure and perpetuates the effects of the increased blood pressure.
Diastolic stress testing is an important imaging modality that can be offered to these patients, ideally as supine bicycle exercise though treadmill stress testing is also possible. 39 when e ′ velocity is reduced at rest and when both average E/e ′ ratio and peak TR velocity are increased with exercise. The specificity of the test appears reduced when only the E/e ′ ratio is used for drawing conclusions about mean wedge pressure. There are very few studies that looked at the accuracy of exercise E/e ′ ratio in identifying elevated invasive LV filling pressure with exercise. In general, acceptable correlations were observed. 42, 43 Natriuretic peptides B-type natriuretic peptide (BNP) and NT-proBNP are elevated in the presence of increased LV end-diastolic wall stress. They are currently used to evaluate patients with dyspnoea as elevated natriuretic peptide levels (BNP >100 pg/mL, NT-proBNP >300 pg/mL) are consistent with a cardiac aetiology for dyspnoea in the acute setting. 44 Some studies looking at their utility in patients with chronic cardiac disease noted lower accuracy in patients with HFrEF and in patients with HFpEF. 21, 43 The lower accuracy may be related to older age as well as other diseases that lead to elevated natriuretic peptide levels such as chronic kidney disease. Conversely, obese patients may have lower natriuretic peptide levels despite the presence of volume overload. 44 The 2016 ESC guidelines recognize the utility of natriuretic peptide levels in the diagnosis of HFpEF but not in isolation. Specifically, the guidelines recommend the constellation of several findings in order to diagnose HFpEF. 44 These findings include the presence of clinical findings of heart failure, an LVEF ≥50%, BNP >35 pg/mL or NT-proBNP >125 pg/mL, as well as evidence of abnormal cardiac structure (LA enlargement and/or LV hypertrophy) and function (reduced annular e ′ velocity, increased E/e ′ ratio, increased peak TR velocity and reduced LV global longitudinal strain).
There are several studies that looked at the relation between echocardiographic indices of LV filling and BNP levels. In general, a direct relation is present between mitral E/A ratio, E/e ′ ratio, and BNP levels, whereby higher ratios are associated with elevated BNP levels. Notwithstanding these studies which support the utility of BNP levels as a surrogate of LV filling pressure, there are data that have shown a higher accuracy of echocardiographic signals. In particular, one study compared BNP levels and E/e ′ ratio against invasively measured mean wedge pressure (all simultaneous measurements). Not only did the E/e ′ ratio relate better to LV filling pressure, but it was also able to track changes in wedge pressure whereas BNP levels did not. 45 It is appealing to consider the presence of elevated natriuretic peptide levels as supportive evidence for the presence of elevated LV filling pressure in patients with suboptimal echocardiographic windows and in patients where LV filling pressure is deemed indeterminate by echocardiography. While plausible, there are no studies yet that support the latter approach.
When to consider cardiac catheterization
There are two major reasons to consider cardiac catheterization, given the implications with respect to cost, patients' preferences, and potential complications. The first scenario is a situation where medical treatment is being titrated repeatedly over a short period of time. In this setting, it is most practical to have an indwelling pulmonary artery catheter for repeated measurements of cardiac index and wedge pressure. The second major reason is in settings where LV filling pressure could not be reliably estimated by echocardiography and there are several situations that can lead to this outcome. They include inability to acquire satisfactory two-dimensional and Doppler signals, pathophysiological situations where several echocardiographic signals could not be used as reliable indicators of LV filling pressure, and a combination of variables that results in the indeterminate category as per the algorithm recommended in the guidelines. Right heart catheterization is usually performed to measure RV and LV filling pressures, pulmonary artery pressures and cardiac index. Further, when there is a high index of suspicion that HFpEF is present, particularly in the presence of a non-diagnostic non-invasive stress test, pressure measurements can be obtained both at rest and with exercise. have shown the accuracy of each of the above estimates in different populations, but most importantly in patients undergoing right heart catheterization in preparation for cardiac transplantation. 46 There are several direct implications for patient care with respect to the assessment of LV filling pressure. For diagnosis, LV filling pressure when assessed at the time of clinical presentation can determine if there is indeed a cardiac aetiology for dyspnoea. Many patients with HFrEF and HFpEF have co-morbid conditions which could be the reason behind the shortness of breath. Importantly, when feasible and correctly applied, echocardiographic assessment of the aetiology of dyspnoea is more accurate than clinical evaluation and natriuretic peptides. 21, 45 Further, the 2016 guidelines for estimation of LV filling pressure are applicable in the presence of myocardial disease irrespective of LVEF, that is they can be applied to patients with HFrEF, HFpEF, and the new category of heart failure with mid-range ejection fraction. 44 As noted earlier, abnormal LV filling is one of the criteria needed to establish the diagnosis of HFpEF. 44 The second direct application is using the changes in cardiac structure and function to decide on whether a given treatment plan is effective or not. The successful treatment of heart failure should lead, among other things, to a decrease in LV filling pressure. There are studies that have shown the utility of Doppler echocardiography in tracking changes in LV filling pressure. 11, 45 Furthermore, the persistence of elevated LV filling pressure despite treatment in patients with HFrEF has been shown to predict total mortality and increased hospitalizations for heart failure exacerbations.
18 -20 Perhaps, the most rewarding application is the use of echocardiography to plan treatment in patients with heart failure. One study looked at echocardiographic measurements of pulmonary artery systolic pressure and stroke volume to titrate diuretics and vasodilators in HFrEF patients in an outpatient setting. This proof of concept study showed the feasibility of this approach in a randomized clinical trial as well as its potential to reduce hospitalizations due to heart failure exacerbations. 47 It remains to be seen if other methods of assessing LV filling can be applied for the same objective and whether such an approach holds promise in HFpEF patients.
Abnormal echocardiographic findings of LA, LV, and RV function can occur in asymptomatic patients and can be further uncovered by looking at LV inotropic reserve (detected by changes in LV ejection indices and LV strain) and LV lusitropic reserve (detected by changes in annular e ′ velocity, diastolic strain rates, E/e ′ ratio, and pulmonary artery systolic pressure) with exercise. One can argue that, if these abnormalities are present in patients with normal ejection fraction, medical treatment should be initiated or titrated upwards. At the present time, there are no data to support this approach, albeit a logical approach.
Direct imaging of pulmonary congestion by lung ultrasound
It is possible to visualize pulmonary congestion by using lung ultrasound to determine the presence and extent of B-lines or comets (Figure 8 ). Successful treatment of pulmonary congestion should lead to a reduction in lung comets. The presence of residual B-line count of ≥30 after treatment was associated with death and heart failure hospitalizations in one study. 48 Thus, this finding could serve as a therapeutic target along with clinical examination and the change in symptomatic status. Interestingly, the number of B-lines was found to be significantly related to pulmonary artery pressures (systolic, diastolic, and mean), pulmonary vascular resistance, as well as RA pressure but no relation was observed with mean wedge pressure. 49 Nevertheless, since the mere presence of comets is related to pulmonary fluid per se, which can have infectious and inflammatory aetiologies, it is best to use lung ultrasound in conjunction with echocardiography.
Conclusions
Non-invasive imaging provides key information on cardiac structure and function. It can be successfully applied to estimate LV filling pressure. It is also possible to image pulmonary fluid using lung ultrasound, all of which can be used to guide therapy and to predict outcome in patients with heart failure. Conflict of interest: none declared.
